We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$169M
AUM Growth
+$6.16M
Cap. Flow
-$15.9M
Cap. Flow %
-9.4%
Top 10 Hldgs %
30.18%
Holding
221
New
53
Increased
41
Reduced
35
Closed
49

Top Buys

Rank Stock Value
1
CMBM
Cambium Networks
CMBM
+$2.89M
2
INDI icon
indie Semiconductor
INDI
+$2.88M
3
ASPN icon
Aspen Aerogels
ASPN
+$2.86M
4
SCPH
scPharmaceuticals
SCPH
+$2.68M
5
BDSX icon
Biodesix
BDSX
+$2.04M

Top Sells

Rank Stock Value
1
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$7.12M
2
MTRN icon
Materion
MTRN
+$4.81M
3
SEV
Sono Group N.V. Common Shares
SEV
+$2.22M
4
SIMO icon
Silicon Motion
SIMO
+$1.88M
5
TTGT icon
TechTarget
TTGT
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 21.33%
3 Financials 6.11%
4 Industrials 3.63%
5 Real Estate 3.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFN
26
DELISTED
Infinera Corporation Common Stock
INFN
$1.39M 0.82%
+205,940
New +$1.25M
BKTI icon
27
BK Technologies
BKTI
$300M
$1.38M 0.82%
83,202
+14,115
+20% +$184K
AIRG icon
28
Airgain
AIRG
$73.4M
$1.17M 0.69%
179,308
-1,000
-0.6% -$7.21K
MRAM icon
29
Everspin Technologies
MRAM
$341M
$1.16M 0.69%
209,362
-9,500
-4% -$55.8K
COF icon
30
Capital One
COF
$128B
$1.15M 0.68%
12,368
+5,704
+86% +$561K
GSK icon
31
GSK
GSK
$104B
$1.12M 0.66%
+31,898
New +$1.06M
CGTX icon
32
Cognition Therapeutics
CGTX
$79.6M
$1.05M 0.62%
501,719
+301,531
+151% +$609K
INCY icon
33
Incyte
INCY
$24.2B
$1.03M 0.61%
+12,800
New +$979K
VICI icon
34
VICI Properties
VICI
$29B
$1.01M 0.6%
+31,308
New +$1.01M
ENV
35
DELISTED
ENVESTNET, INC.
ENV
$995K 0.59%
16,128
-3,151
-16% -$168K
COHR icon
36
Coherent
COHR
$51.4B
$899K 0.53%
+25,600
New +$890K
THER
37
DELISTED
THERATECHNOLOGIES INC COM
THER
$848K 0.5%
952,024
+208,601
+28% +$186K
PCGU
38
DELISTED
PG&E Corporation
PCGU
$844K 0.5%
+5,859
New +$792K
APEN
39
DELISTED
Apollo Endosurgery, Inc.
APEN
$775K 0.46%
77,696
-48,839
-39% -$364K
LUV icon
40
Southwest Airlines
LUV
$22B
$768K 0.45%
22,818
+2,041
+10% +$73.6K
SCYX icon
41
SCYNEXIS
SCYX
$48.1M
$742K 0.44%
59,426
-1,900
-3% -$33.6K
BKNG icon
42
Booking.com
BKNG
$149B
$721K 0.43%
8,950
-900
-9% -$68.3K
COYA icon
43
Coya Therapeutics
COYA
$98.3M
$638K 0.38%
+137,758
New +$641K
RFIL icon
44
RF Industries
RFIL
$134M
$637K 0.38%
124,944
-3,740
-3% -$19.7K
LPTH icon
45
Lightpath Technologies
LPTH
$651M
$609K 0.36%
499,425
-10,000
-2% -$11.3K
ITI
46
DELISTED
Iteris, Inc.
ITI
$606K 0.36%
194,713
-78,231
-29% -$229K
CDLX icon
47
Cardlytics
CDLX
$21.7M
$597K 0.35%
10,323
+5,161
+100% +$319K
CLRB icon
48
Cellectar Biosciences
CLRB
$20.5M
$576K 0.34%
11,220
+9,832
+708% +$589K
IPWR icon
49
Ideal Power
IPWR
$60.8M
$558K 0.33%
52,588
-300
-0.6% -$3.38K
ISEE
50
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$546K 0.32%
+25,500
New +$544K
1
2
3 4 5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Worth Venture Partners held 221 positions worth $169M, up 3.8% from $163M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Worth Venture Partners withdrew a net $15.9M in Q4 2022, closing 49 positions and reducing 35 holdings. Its most notable exit was Materion, an estimated $4.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Worth Venture Partners opened a new position in Cambium Networks worth $3.11M.

  • Worth Venture Partners's largest Q4 2022 buy was Cambium Networks: 143,499 shares worth $3.11M.
  • Worth Venture Partners added most to indie Semiconductor in Q4 2022, an estimated $2.88M increase.
  • Worth Venture Partners's biggest Q4 2022 reduction was AVEO Pharmaceuticals, Inc., cutting an estimated $7.12M.
  • Worth Venture Partners fully exited Materion in Q4 2022, selling an estimated $4.81M.
  • Worth Venture Partners's ten largest holdings make up 30% of its $169M portfolio in Q4 2022.
  • Worth Venture Partners opened 53 new positions and closed 49 in Q4 2022.
  • Worth Venture Partners's portfolio value rose 3.8% quarter-over-quarter to $169M.

Based on Worth Venture Partners's 13F filing for Q4 2022, filed 14 Feb 2023.